Comparison of In-Hospital Outcomes After Percutaneous Revascularization for Peripheral Arterial Disease in Patients With a Body Mass Index of >30 kg/m2 Versus ≤30 kg/m2 (from the National Inpatient Sample)

American Journal of Cardiology

Volumn 120, Issue 9, 2017, Pages 1648-1652

  Doshi, Rajkumar ^a   Rao, Gaurav ^a   Shlofmitz, Evan ^a   Donnelly, Joseph ^a   Meraj, Perwaiz ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ANGIOPLASTY; ARTICLE; ATHERECTOMY; BARE METAL STENT; BODY MASS; CHARLSON COMORBIDITY INDEX; COMORBIDITY; CONTROLLED STUDY; DRUG ELUTING STENT; ENDOVASCULAR SURGERY; FEMALE; HEALTH CARE COST; HUMAN; ICD-9-CM; KIDNEY FAILURE; LEG REVASCULARIZATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OBESITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; SEX DIFFERENCE; TREATMENT OUTCOME; AGED; COHORT ANALYSIS; COMPARATIVE STUDY; COMPLICATION; HOSPITAL MORTALITY; HOSPITALIZATION; MIDDLE AGED; MORTALITY; PERIPHERAL ARTERIAL DISEASE;

AGED; BODY MASS INDEX; COHORT STUDIES; DRUG-ELUTING STENTS; ENDOVASCULAR PROCEDURES; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; OBESITY; PERIPHERAL ARTERIAL DISEASE; TREATMENT OUTCOME;

EID: 85028079752     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2017.07.065     Document Type: Article

References (26)

1. Ogden, C.L., Carroll, M.D., Flegal, K.M., Prevalence of obesity in the United States. JAMA 312 (2014), 189–190.
2. Hubert, H.B., Feinleib, M., McNamara, P.M., Castelli, W.P., Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67 (1983), 968–977.
3. Calle, E.E., Thun, M.J., Petrelli, J.M., Rodriguez, C., Heath, C.W. Jr, Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 341 (1999), 1097–1105.
4. Oreopoulos, A., Padwal, R., Kalantar-Zadeh, K., Fonarow, G.C., Norris, C.M., McAlister, F.A., Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 156 (2008), 13–22.
5. Romero-Corral, A., Montori, V.M., Somers, V.K., Korinek, J., Thomas, R.J., Allison, T.G., Mookadam, F., Lopez-Jimenez, F., Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 368 (2006), 666–678.
6. Galal, W., van Gestel, Y., Hoeks, S.E., Sin, D.D., Winkel, T.A., Bax, J.J., Verhagen, H., Awara, A.M.M., Klein, J., van Domburg, R.T., Poldermans, D., The obesity paradox in patients with peripheral arterial disease. Chest 134 (2008), 925–930.
7. Galal, W., van Domburg, R.T., Feringa, H.H., Schouten, O., Elhendy, A., Bax, J.J., Awara, A.M., Klein, J., Poldermans, D., Relation of body mass index to outcome in patients with known or suspected coronary artery disease. Am J Cardiol 99 (2007), 1485–1490.
8. Golledge, J., Cronin, O., Iyer, V., Bradshaw, B., Moxon, J.V., Cunningham, M.A., Body mass index is inversely associated with mortality in patients with peripheral vascular disease. Atherosclerosis 229 (2013), 549–555.
9. Cacoub, P.P., Abola, M.T., Baumgartner, I., Bhatt, D.L., Creager, M.A., Liau, C.S., Goto, S., Rother, J., Steg, P.G., Hirsch, A.T., Investigators, R.R., Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Atherosclerosis 204 (2009), e86–e92.
10. Mukherjee, D., Lingam, P., Chetcuti, S., Grossman, P.M., Moscucci, M., Luciano, A.E., Eagle, K.A., Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2). Circulation 106 (2002), 1909–1912.
11. HCUP National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP). 2012, Agency for Healthcare Research and Quality R, MD.
12. Elixhauser, A., Steiner, C., Harris, D.R., Coffey, R.M., Comorbidity measures for use with administrative data. Med Care 36 (1998), 8–27.
13. Kato, J., Obesity paradox in peripheral vascular disease. Atherosclerosis 229 (2013), 509–510.
14. Wannamethee, G., Shaper, A.G., Body weight and mortality in middle aged British men: impact of smoking. BMJ 299 (1989), 1497–1502.
15. Lainscak, M., von Haehling, S., Doehner, W., Anker, S.D., The obesity paradox in chronic disease: facts and numbers. J Cachexia Sarcopenia Muscle 3 (2012), 1–4.
16. Fonarow, G.C., Srikanthan, P., Costanzo, M.R., Cintron, G.B., Lopatin, M., Committee ASA and Investigators. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J 153 (2007), 74–81.
17. Curtis, J.P., Selter, J.G., Wang, Y., Rathore, S.S., Jovin, I.S., Jadbabaie, F., Kosiborod, M., Portnay, E.L., Sokol, S.I., Bader, F., Krumholz, H.M., The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 165 (2005), 55–61.
18. Anker, S.D., Chua, T.P., Ponikowski, P., Harrington, D., Swan, J.W., Kox, W.J., Poole-Wilson, P.A., Coats, A.J., Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 96 (1997), 526–534.
19. Levine, B., Kalman, J., Mayer, L., Fillit, H.M., Packer, M., Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323 (1990), 236–241.
20. Hasper, D., Hummel, M., Kleber, F.X., Reindl, I., Volk, H.D., Systemic inflammation in patients with heart failure. Eur Heart J 19 (1998), 761–765.
21. Ellis, S.G., Elliott, J., Horrigan, M., Raymond, R.E., Howell, G., Low-normal or excessive body mass index: newly identified and powerful risk factors for death and other complications with percutaneous coronary intervention. Am J Cardiol 78 (1996), 642–646.
22. Gruberg, L., Weissman, N.J., Waksman, R., Fuchs, S., Deible, R., Pinnow, E.E., Ahmed, L.M., Kent, K.M., Pichard, A.D., Suddath, W.O., Satler, L.F., Lindsay, J. Jr, The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox?. J Am Coll Cardiol 39 (2002), 578–584.
23. Ortiz, D., Jahangir, A., Singh, M., Allaqaband, S., Bajwa, T.K., Mewissen, M.W., Access site complications after peripheral vascular interventions: incidence, predictors, and outcomes. Circ Cardiovasc Interv 7 (2014), 821–828.
24. Delhaye, C., Wakabayashi, K., Maluenda, G., Belle, L., Ben-Dor, I., Gonzalez, M.A., Gaglia, M.A. Jr, Torguson, R., Xue, Z., Suddath, W.O., Satler, L.F., Kent, K.M., Lindsay, J., Pichard, A.D., Waksman, R., Body mass index and bleeding complications after percutaneous coronary intervention: does bivalirudin make a difference?. Am Heart J 159 (2010), 1139–1146.
25. Hall, J.E., Crook, E.D., Jones, D.W., Wofford, M.R., Dubbert, P.M., Mechanisms of obesity-associated cardiovascular and renal disease. Am J Med Sci 324 (2002), 127–137.
26. Tsai, T.T., Patel, U.D., Chang, T.I., Kennedy, K.F., Masoudi, F.A., Matheny, M.E., Kosiborod, M., Amin, A.P., Messenger, J.C., Rumsfeld, J.S., Spertus, J.A., Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. JACC Cardiovasc Interv 7 (2014), 1–9.